Avidity Biosciences

Avidity engineers RNA therapeutics with targeting ligands—combining oligonucleotides with cell-specific delivery like guided missiles. Their AOCs bind muscle cells selectively, treating rare diseases by editing genetic instructions in precise tissue types, targeted evolution at molecular scale.